Publications
Article type
Sort:
Open Access Letter Issue
CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy
Cancer Biology & Medicine 2025, 22(5): 496-501
Published: 06 May 2025
Abstract PDF (213.3 KB) Collect
Downloads:38
Total 1